Research communications in molecular pathology and pharmacology.
Discontinued
Publisher:
PJD Publications,
Frequency: Monthly
Country: United States
Language: English
Start Year:1994 - 2010
Identifiers
| ISSN: | 1078-0297 (Print) 1078-0297 (Linking) |
| NLM ID: | 9437512 |
| (DNLM): | SR0081508(s) |
| (OCoLC): | 30890166 |
| Coden: | RCMPE6 |
| Classification: | W1 RE216HM |
Effects of topical application of pirfenidone ointment on thermoplasty-induced acute lameness in a double-blind and acute and chronic lameness of musculoskeletal origin in an open multi-centered field trial in horses. The effectiveness of pirfenidone ointment against thermoplasty-induced acute foreleg lameness in a double-blind study, and against acute and chronic lameness of musculoskeletal origin in an open multi-centered field trial was evaluated in this study. Thermoplasty was performed on both inner forelegs at designated locations of each horse under anesthetics. A 10% pirfenidone or placebo ointment was topically applied starting 24 hours after the thermoplasty three times daily for 7 days. For acute and chronic lameness of musculoskeletal origin, pirfenidone ointment was also applied one to three ti...
Modulation of articular chondrocyte activity by pirfenidone. Pirfenidone is under investigation as an anti-inflammatory and anti-fibrotic agent in several organs including lung. Since important features of arthritic conditions include inflammation and long-term damage to articular cartilage, we have investigated whether PD can suppress chondrocyte responses to bacterial lipopolysaccharide (LPS) and interleukin 1 (IL-1); modulators that induce a cascade of inflammatory responses that lead to articular joint tissue damage. PD (0 - 5microM) showed no effect on cell number or viability when incubated with high density primary equine chondrocyte cultures for...